Скачать с ютуб Pioneering Community-Based Drug Development for Fragile X - FRAXA Research Foundation в хорошем качестве

Pioneering Community-Based Drug Development for Fragile X - FRAXA Research Foundation

Explore the essence of Community-Based Drug Development with FRAXA's Dr. Michael Tranfaglia, as presented at the 2023 GRI Conference. Hosted by the CureGRIN Foundation in Boston, MA from March 23-26, this event brought together key stakeholders in the field of rare disease research. In this insightful talk, Dr. Tranfaglia shares his expertise on the pioneering efforts in developing new treatments for Fragile X syndrome using a community-based approach. For more detailed insights, visit our related article at https://www.fraxa.org/pioneering-comm... - a comprehensive guide on how FRAXA Research Foundation leverages community-based drug development to advance Fragile X syndrome therapeutics. FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments. Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders. To learn more about FRAXA's Fragile X syndrome research, to get involved with Fragile X awareness and events or to donate to FRAXA research, visit www.fraxa.org Let's Connect Facebook:   / fraxaresearch   Instagram:   / fraxaresearch   LinkedIn:   / fraxa-research-foundation   Twitter:   / fraxaresearch   Website: https://www.fraxa.org